Inno Supps Trim Biome GLP-1 Review 2026: A Sugar-Blocker Sold to Take Without Sugar

Serving size 2 capsules. Servings per container 30.

The largest ingredient by mass is Sukré™, and the label identifies it as L-arabinose — a five-carbon sugar found in plant cell walls, molecular weight about 150. L-arabinose is not a stimulant, a hormone or a probiotic. It is a selective sucrase inhibitor. It sits on the enzyme in your small intestine that splits sucrose into glucose and fructose, slowing that reaction. Undigested sucrose then passes into the colon, where bacteria ferment it — which is where the indirect GLP-1 argument comes from, since colonic fermentation produces short-chain fatty acids that stimulate L-cells. That mechanism is real, and it has been studied in humans. But it comes with two conditions that decide everything. Condition one: it only does anything if you are eating sucrose. This is definitional, not a caveat. A sucrase inhibitor with no sucrose to act on is inert. In the human studies, L-arabinose was always added *to* a sucrose-containing food — that is the only way to test it. Condition two: the dose is set as a proportion of the sucrose, not as a fixed amount. The studies added L-arabinose at around 10% of the sucrose content of a food containing roughly 50 g of available carbohydrate. Run that against this product. 500 mg of L-arabinose is 10% of 5 grams of sucrose — about a teaspoon and a half. So for the studied ratio to hold, you would have to take these capsules alongside a meal containing roughly a teaspoon and a half of sugar, and no more. And the label tells you to take them "with or without food."

It gets harder for this ingredient, and in fairness we should present the strongest version of the evidence on both sides. Where L-arabinose has looked good: in sugary drinks. A review of L-arabinose and D-xylose found that in a fruit-based drink, glucose and insulin peaks were significantly lower with these pentoses than with control (P < 0.01). That is a genuine result. Where it has not: in food. The same review found that in a muffin, glucose responses showed no significant difference, with insulin only "tending" to be lower. Its authors concluded that efficacy "appears to depend on the food matrix." Then there is the direct test. A 2015 study in the *British Journal of Nutrition* ran two randomised, double-blind, crossover trials in healthy men — 17 in the first, 6 in the second — adding L-arabinose at 5%, 10% and 20% by weight to breakfast meals containing sucrose and wheat starch, plus a liquid meal with maltose. The result, in the authors' words: "The peak plasma concentration, time to reach peak plasma concentration or AUC values of glucose, insulin and C-peptide were not altered after consumption of the test meals." Their conclusion was that it "was not possible to reproduce the beneficial effects of L-arabinose added to sucrose drinks when L-arabinose was mixed in a solid or semi-solid mixed meal." So the honest summary of this ingredient: it blunts the glucose spike from sugar-sweetened drinks, at a dose proportional to the sugar, and this effect did not survive translation to actual meals at doses up to 20% by weight — far above what this capsule delivers.

Berberine hydrochloride at 400 mg per serving is the second-largest ingredient, and it is the one with the most substantial evidence base in the bottle. Berberine genuinely lowers fasting glucose and HbA1c in randomised trials and meta-analyses, improves lipid markers, and activates AMPK. It is a real pharmacological agent, and it is the compound that TikTok nicknamed "nature's Ozempic." The problem is arithmetic again. Berberine's oral bioavailability is under 1%, which is precisely why studied protocols use 500 mg two or three times a day — 1,000 to 1,500 mg daily. Trim Biome delivers 400 mg per day, which is roughly 27% to 40% of the low end of that range. That is not a token sprinkle — 400 mg is a meaningful amount, and more than many blends contain. But it is well under the exposure that produced the published results, in a compound whose entire dosing rationale is that you need a lot to absorb a little. Even at full dose, note what berberine actually does: the weight effects in trials are small, typically a couple of kilograms or less. It is a glucose-and-lipid compound, not a weight-loss drug.

Something becomes visible once you have read more than one of these labels. Here is Inno Supps Trim Biome GLP-1 next to Bioma's GLP-1 Booster, a product from an unrelated brand at a different price point:

TriBiome™ (Triacetin), 200 mg. Triacetin is glycerol triacetate — a food additive with GRAS status, used commercially as a solvent, humectant and plasticiser. It is metabolised to glycerol and acetate, and acetate is a genuine short-chain fatty acid, so calling it a postbiotic precursor is chemically defensible rather than nonsense. The issue is scale. A colon fermenting an adequate fiber intake produces short-chain fatty acids in grams per day. Two hundred milligrams of an acetate precursor is a rounding error against that. If short-chain fatty acids are what you are after, fiber delivers them by orders of magnitude more. ***Akkermansia muciniphila*, 10 mg.** This is the scientifically interesting organism in the metabolic microbiome literature, and its foundational human trial is worth knowing accurately. In 2019, a randomised, double-blind, placebo-controlled pilot published in *Nature Medicine* gave overweight, insulin-resistant volunteers 10^10 bacteria daily, live or pasteurized, for three months — 40 enrolled, 32 completed. The pasteurized arm improved insulin sensitivity by 28.6% (p=0.002), cut insulinaemia by 34.1% (p=0.006) and lowered total cholesterol by 8.7% (p=0.02). Body weight fell 2.27 kg versus placebo — and that did not reach statistical significance (p=0.091). That trial dosed in cells. This label says 10 mg. Milligrams and viable cell counts are not interchangeable without knowing the potency of the raw material, which is not disclosed. And the label does not say whether the organisms are live or pasteurized — a distinction that decides whether the trial above applies at all, since pasteurized was the arm that produced the results and live *A. muciniphila* is a strict anaerobe that is difficult to keep viable in a shelf-stable capsule.

There is a narrow case. If you specifically want a moderate berberine dose in a capsule alongside some prebiotic and postbiotic extras, and you would take it with meals rather than as directed, this is a fully-disclosed label from a company that tells you what is in it. That is worth something in this category. If berberine is what you want, buy berberine. Single-ingredient berberine is widely available at the studied 500 mg dose, from brands with third-party testing, at a fraction of $59.99 a month. You will get more of the active compound for less money, and you will know exactly what you are taking. Skip it if: you are buying it to "supercharge GLP-1" or to lose weight — no trial of this finished product exists, and its two largest ingredients are a sucrase inhibitor at a dose matched to a teaspoon and a half of sugar and a berberine dose below the studied range; or you take prescription medication, in which case 400 mg of berberine is a real interaction consideration rather than a theoretical one. Do not take it in pregnancy or while breastfeeding, because of berberine. And if you do take it, take it with food — with a meal containing some sucrose, in fact — regardless of what the directions say. A sucrase inhibitor on an empty stomach has nothing to inhibit.

What is in Inno Supps Trim Biome GLP-1? Per 2-capsule serving: Sukré (L-arabinose) 500 mg, berberine hydrochloride 400 mg, TriBiome (triacetin) 200 mg, and *Akkermansia muciniphila* 10 mg. Sixty capsules, 30 servings, $59.99. What is Sukré? The label identifies it as L-arabinose, a pentose sugar that acts as a selective intestinal sucrase inhibitor. It slows the digestion of sucrose — which means it only has an effect when sucrose is present. Does it actually boost GLP-1? There is no published trial of this finished product. The indirect argument is that undigested sucrose ferments in the colon and produces short-chain fatty acids that stimulate GLP-1 release. That chain of events requires you to be eating sucrose, and the dose here corresponds to roughly 5 g of it. Why does taking it "with or without food" matter? Because a sucrase inhibitor has nothing to act on without food containing sucrose. The label's own directions permit a way of taking the product in which its largest ingredient cannot work. Is 400 mg of berberine enough? It is a meaningful amount but below the studied range. Clinical protocols generally use 500 mg two to three times daily — 1,000 to 1,500 mg a day — because berberine's oral bioavailability is under 1%. Is it safe with semaglutide or tirzepatide? Ask your prescriber. Berberine lowers blood glucose and inhibits CYP3A4 and P-glycoprotein, so it can interact with other medications and add to your GLP-1's glucose-lowering effect. What are the side effects? Berberine commonly causes gastrointestinal effects — cramping, constipation or diarrhoea. L-arabinose that reaches the colon can cause gas and bloating, which is the expected consequence of its mechanism. Is it the same as Bioma's GLP-1 Booster? Not identical, but they share three branded ingredients, with triacetin at 200 mg and *Akkermansia* at 10 mg in both — the signature of a shared branded-ingredient system rather than independently developed formulas. Is Inno Supps legitimate? Yes. It is a real company shipping a real product with a fully disclosed label, which is more than several competitors manage. Our criticism is of the pharmacology as dosed and directed, not of whether the company exists or delivers.